Skip to content

Bioavailability of Pea Protein in Young and Old Volunteers

Study of Comparative Bioavailability, Randomized, in Open Cross Over the Kinetics of Subsequent Plasma Amino Acid Concentrations the Consumption of Pea Protein NUTRALYS ® S85 Plus.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06381869
Acronym
NUTRALYS
Enrollment
30
Registered
2024-04-24
Start date
2019-01-10
Completion date
2019-06-13
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Male Volunteers

Keywords

Protein, Bioavailability, Pea protein, Amino acidemia

Brief summary

The aim of this study done in healthy, non-malnourished young and elderly subjects, is to measure the bioavailability of protein intake and the variation of metabolic markers following consumption of pea protein NUTRALYS ® S85 plus or a reference protein brought in water either alone or at the end of a standardized meal.

Interventions

DIETARY_SUPPLEMENTPea protein (NUTRALYS ® S85 plus) in water

After selection and randomization, the subjects will consume per os Pea protein (NUTRALYS® S85 plus) in water containing 0,41 g of tested protein/kg of body weight.

DIETARY_SUPPLEMENTPea protein (NUTRALYS ® S85 plus) within meal

After selection and randomization, the subjects will consume per os Pea protein (NUTRALYS® S85 plus) within a meal containing 0,41 g of tested protein/kg of body weight.

DIETARY_SUPPLEMENTWhey protein in water

After selection and randomization, the subjects will consume per os whey protein in water containing 0,41 g of tested protein/kg of body weight.

DIETARY_SUPPLEMENTWhey protein within meal

After selection and randomization, the subjects will consume per os whey protein within a meal containing 0,41 g of tested protein/kg of body weight.

Sponsors

Centre de Recherche en Nutrition Humaine d'Auvergne
CollaboratorOTHER_GOV
Université d'Auvergne
CollaboratorOTHER
Roquette Freres
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult male volunteers, aged over 65 or under 30 * Body mass index (weight in kg/ height² in m²) between 22 and 28 kg/m², * Subjects considered to be healthy by the principal investigator doctor according to the interview, medical and clinical examination, * Biological assessment considered compatible with participation in the study, * Persons able to sign the informed consent, * Persons affiliated to social security scheme.

Exclusion criteria

* Pathologies or treatments not compatible with the study * Food allergy or a contraindication to the consumption of the products tested * Subject in a situation which, in the opinion of the investigator, could interfere with their optimal participation in the study or constitute a particular risk for the subject, * Subject with a particular diet (vegetarians, vegans, nutritional supplements, etc.), * Subject weighing \< 55 kg,

Design outcomes

Primary

MeasureTime frame
Leucine blood concentration0 minute before eating the test meals, then regularly until 360 minutes after ingestion.

Secondary

MeasureTime frame
Blood insulin concentration (μIU/ml)0 minute before eating the test meals, then regularly until 360 minutes after ingestion.
Non essential amino acid blood concentration (µmol/L)0 minute before eating the test meals, then regularly until 360 minutes after ingestion.
Blood glucose concentration (g/L)0 minute before eating the test meals, then regularly until 360 minutes after ingestion.
Blood lipid profile (glycerol concentration in mg/l and non-esterified fatty acids concentration in mg/l)0 minute before eating the test meals, then regularly until 360 minutes after ingestion.
Blood inflammatory profile (TNF-α blood concentration in pg/ml and IL-6 blood concentration in pg/ml)0 minute before eating the test meals, then regularly until 360 minutes after ingestion.
Essential amino acids blood concentration (µmol/L)0 minute before eating the test meals, then regularly until 360 minutes after ingestion.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026